Uv Flu Technologies(OTC) UVFT

UV Flu Technologies, Inc. is a company based in Lincolnshire, Illinois, specializing in the research, development, production, and distribution of advanced air purification systems. The company primarily serves the U.S. market with innovative products designed to eliminate hazardous microbes in various environments.

Products and Services

• ViraTech UV-400, an advanced air purification system using germicidal UV radiation
• RX Air product line featuring HEPA technology air purifiers
• Solutions for diverse environments including hospitals, hotels, and military facilities

Growth Outlook

• Increasing demand for air purification solutions amid growing health concerns
• Expansion opportunities in commercial and residential markets
• Potential for strategic partnerships to enhance product distribution

Financial Highlights

• Recent quarterly revenue of $52,976, showing a focus on operational efficiency
• Trailing twelve months (TTM) gross profit margin at 11.34%, indicating product viability
• Current ratio of 0.16, highlighting liquidity challenges but potential for improvement

UV Flu Technologies, Inc. operates in the industrial pollution and treatment controls sector, focusing on innovative air purification technologies. The flagship product, ViraTech UV-400, utilizes advanced germicidal UV radiation to actively capture and eliminate harmful microbes, setting it apart from traditional filtration systems. The RX Air product line complements this offering with HEPA technology, catering to a wide range of environments, including healthcare and hospitality. The growth outlook for UV Flu Technologies is promising, driven by an increasing awareness of air quality and health implications. The company is well-positioned to capitalize on the rising demand for effective air purification solutions. Opportunities for expansion into both commercial and residential markets, along with potential strategic partnerships, could further enhance its market presence. Financially, the company reported a recent quarterly revenue of $52,976, reflecting ongoing efforts to streamline operations. The TTM gross profit margin of 11.34% suggests that the products are gaining traction in the market. However, the current ratio of 0.16 indicates liquidity challenges that may need to be addressed for sustainable growth. Overall, UV Flu Technologies, Inc. presents an intriguing opportunity for investors interested in the air purification industry.